We describe a case of a 69-year-old woman who developed rapidly progressive hepatocellular carcinoma (HCC) associated with autoimmune hepatitis (AIH) after a 7-year follow-up. Markers for viral hepatitis were negative. Serum tumor markers including alpha-fetoprotein and prothrombin induced by vitamin K absence II rose suddenly, and a large tumor was detected in spite of regular surveillance for HCC. Surgical treatment was performed. The resected liver specimen revealed well to moderately differentiated HCC. Ki67 staining showed rapid proliferation of the HCC. Although the incidence of HCC in patients with AIH has been unclarified, the possible complication by HCC must not be overlooked.
Introduction
Autoimmune hepatitis (AIH) is an unresolving inflammation of the liver of unknown cause, which often progresses to cirrhosis and carries a high mortality without any treatment (1) (2) (3) . Therefore, early diagnosis and adequate immunosuppressive therapy is important (1) .
Hepatocellular carcinoma (HCC) is the sixth leading type of cancer worldwide and an important complication of chronic liver disorders. Most HCCs develop in patients with liver cirrhosis of various etiologies (4) . Patients with hepatitis B virus and hepatitis C virus infection, alcoholic cirrhosis, genetic hemochromatosis, or primary biliary cirrhosis are at high risk of developing HCC (5) (6) (7) (8) (9) . AIH is one of the chronic liver diseases that also progresses to liver cirrhosis (1, 10) . However, the incidence of HCC in patients with AIH is still unclear, because the reported incidence of HCC in patients with AIH varies (1, (11) (12) (13) (14) (15) (16) (17) . Here we report a case of type 1 AIH in which HCC developed very rapidly.
Case Report
A 69-year-old woman was diagnosed with type 1 AIH in 2001 because of elevated serum alanine aminotransferase and aspartate aminotransferase, positive anti-nuclear antibody (×160), and a high concentration of serum immunoglobulin G (5,000 mg/dL) ( Table 1) . Histological findings demonstrated interface hepatitis and plasma cell infiltration in the portal area. There was no evidence of steatosis or cirrhosis ( Fig. 1 ). Hepatitis B virus surface antigen (HBs Ag) and anti-hepatitis C virus (HCV) antibody were negative. She received 40 mg/day of prednisolone and her serum level of albumin and transaminases improved. The dose of prednisolone was tapered. She was then followed at our outpatient clinic, where she received 2 mg/day of prednisolone and 600 mg/day of ursodeoxycholic acid. She remained in stable condition with normal concentrations of serum transaminases. Surveillance for HCC was performed by ultrasonography twice a year, by measurement of alphafetoprotein (AFP) every 2 months and by prothrombin induced by vitamin K absence II (PIVKA II) every 4 months. negative. Laboratory findings of this case at the time of diagnosis of HCC are shown in Table 1 . Her clinical course had been stable for 7 years and biochemical data improved except for tumor markers. The tumor was resected surgically. Histology of the resected liver specimen confirmed well to moderately differentiated HCC (Fig. 4a ). Immunohistochemical analysis revealed that many cells in one tumor were strongly positive for Ki-67 ( Fig. 4b and 4c ). Although endoscopy did not reveal esophageal or gastric varices, the ultrasound at the diagnosis of HCC revealed findings of atrophy of the right lobe, hypertrophy of the left lobe, heterogeneity of liver parenchyma, irregular surface of the liver and splenomegaly, suggesting the presence of cirrhosis. But the histological diagnosis of the non-cancerous portions of the resected liver was not cirrhosis but rather chronic hepatitis ( Fig. 4d ).
Discussion
HCC is one of the most common malignancies worldwide. The primary risk factor for the development of HCC is cirrhosis, irrespective of the etiology of the liver injury. The incidence of HCC has been unclear in patients with AIH and it varies among reports (11) (12) (13) (14) (15) (16) (17) . The present pa- tient was diagnosed with type 1 AIH 7 years before the detection of HCC according to the diagnostic criteria for AIH (2, 18) . The risk factors of HCC in patients with AIH are male gender, history of blood transfusion, feature of portal hypertension, treatment failure, long-term immunosuppressive treatment and cirrhosis (12, 17) . Cirrhosis in patients with AIH is clearly associated with the development of HCC (11) (12) (13) 17) . Although the histological finding was chronic hepatitis, cirrhosis was suggested in the present patient based on ultrasonography, computed tomography, platelet count and a serum concentration of hyaluronic acid of 182 ng/mL. However, histological variation may exist in the liver as previously demonstrated (19, 20) . Although our specimen was surgically resected tissue, this finding indicates that we must consider liver cirrhosis even if we do not obtain the evidence of cirrhosis by liver biopsy. The dose of prednisolone was very low (2 mg/day), and treatment of hepatitis was successful. The relationship between immunosuppressive therapy and the development of HCC may be important (12, 21, 22) . However, other immunosuppressive agents such as azathioprine were not used in the present patient. We looked for a possible association with other liver diseases. She was negative for HBs Ag, anti-HBs antibody, HBV DNA, anti-HCV antibody or HCV RNA. We did not examine the HBV DNA or HCV RNA in the liver tissue, however, we believe the possibility of an association with HBV or HCV is low because of the serological results. She was not a drinker and hemochromatosis was unlikely because of her serum ferritin concentration. She had no history of blood transfusion. Therefore, it appears that the HCC in the present patient was directly associated with AIH. Ultrasonography at 5 months before the detection of HCC did not reveal any tumor in the liver. The serum concentration of PIVKA II at 4 months before the detection of HCC was normal (18 mAU/mL) and serum concentration of AFP at 4 and 2 months before the detection of HCC were 30.5 and 38.1 ng/mL, respectively. Therefore, the HCC proliferated very rapidly. Histological examination of the resected tumor demonstrated well to moderately differentiated HCC. Ki-67 is a proliferation-related antigen expressed in late G1, S, G2 and M phases of the cell cycle. Ki-67 staining is now commonly used to assess tumor proliferation (23) . In the present case, tumor cells in the resected liver specimen were strongly positive for Ki-67, which is consistent with rapid progression of the tumor.
In conclusion, we report a patient with type 1 AIH who experienced rapid progression of HCC. Careful surveillance for HCC is also needed in clinically suggested cirrhotic pa-tients with AIH.
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